Association between thyroid hormones, lipids and oxidative stress biomarkers in overt hypothyroidism

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 11, 2010, Pages 1635-1639

  Santi, Adriana ^a   Duarte, Marta Maria Medeiros Frescura ^a   Moresco, Rafael Noal ^a   Menezes, Charlene ^a   Bagatini, Margarete Dulce ^a   Schetinger, Maria Rosa Chitolina ^a   Loro, Vania Lucia ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Hypothyroidism; Lipids; Oxidative stress; Thyroid hormones

Indexed keywords

ALPHA TOCOPHEROL; BIOLOGICAL MARKER; CATALASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIOTHYRONINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THYROID HORMONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FREE THYROXINE INDEX; HUMAN; HYPERCHOLESTEROLEMIA; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ANTIOXIDANTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLESTEROL; FEMALE; HUMANS; HYPOTHYROIDISM; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; THYROID HORMONES;

EID: 78751639476     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.309     Document Type: Article

References (36)

1. Biondi B, Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 2004;24:1-13.
2. Duntas LH. Thyroid disease and lipids. Thyroid 2002;12:287-93.
3. Efstathiadou Z, Bitsis S, Milionis HJ, Kukuvitis A, Bairaktari ET, Elisaf MS, et al. Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial? Eur J Endocrinol 2001;145:705-10.
4. Becerra A, Bellido D, Luengo A. Lipoprotein (a) and other lipoproteins in hypothyroid patients before and after thyroid replacement therapy. Clin Nutr 1999;18:319-22.
5. Sundaram V, Hanna AN, Koneru L, Newman H A I, Falko JM. Both hypothyroidism and hyperthyroidism enhance low-density lipoprotein oxidation. J Clin Endocrinol Metab 1997;82:3421-4.
6. Diekman T, Demacker PN, Kastelein JJ, Stalenhoef AF, Wiersinga WM. Increased oxidizability of low-density lipoproteins in hypothyroidism. J Clin Endocrinol Metab 1998;83:1752-5.
7. Duarte MM, Loro VL, Rocha JB, Leal DB, Bem AF, Dorneles A, et al. Enzymes that hydrolyze adenine nucleotides of patients with hypercholesterolemia and inflammatory process. FEBS J 2007;274:2707-14.
8. Prasad K, Kalra J. Oxygen free radicals and hypercholesterolemic atherosclerosis. Am Heart J 1993;125:958-71.
9. Zou Y, Lu Y, Wei D. Hypocholesterolemic effects of a flavonoid-rich extract of Hypericum perforatum L. in rats fed a cholesterol-rich diet. J Agric Food Chem 2005;53:2462-6.
10. Kebapcilar L, Akinci B, Bayraktar F, Comlekci A, Solak A, Demir T, et al. Plasma thiobarbituric acid-reactive substance levels in subclinical hypothyroidism. Med Princ Pract 2007;16:432-6.
11. Nanda N, Bobby Z, Hamide A, Koner BC, Sridhar MG. Association between oxidative stress and coronary lipid risk factors in hypothyroid women is independent of body mass index. Metabolism 2007;56:1350-5.
12. Costantini F, Pierdomenico SD, De Cesare D, De Remigis P, Bucciarelli T, Bittolo-Bon G, et al. Effect of thyroid function on LDL oxidation. Arterioscler Thromb Vasc Biol 1998;5:732-7.
13. Torun AN, Kulaksizoglu S, Kulaksizoglu M, Pamuk BO, Isbilen E, Tutuncu NB. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Clin Endocrinol 2009;70:469-74.
14. Maggi-Capeyron MF, Cases J, Badia E, Cristol JP, Rouanet JM, Besançon P, et al. A diet high in cholesterol and deficient in vitamin E induces lipid peroxidation but does not enhance antioxidant enzyme expression in rat liver. J Nutr Biochem 2002;13:296-301.
15. Lazzarino G, Raatikainen P, Nuutinen M, Nissinen J, Tavazzi B, Di Pierrô D, et al. Myocardial release of malondialdehyde and purine compounds during coronary bypass surgery. Circulation 1994;90:291-7.
16. Nelson SK, Bose SK, Grunwald GK, Myhill P, McCord JM. The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy. Free Radic Biol Med 2006;40:341-7.
17. Messarah M, Boulakoud MS, Boumendjel A, Abdennour C, El Feki A. The impact of thyroid activity variations on some oxidizing-stress parameters in rats. C R Biol 2007;330:107-12.
18. Nanda N, Bobby Z, Hamide A. Association of thyroid stimulating hormone and coronary lipid risk factors with lipid peroxidation in hypothyroidism. Clin Chem Lab Med 2008;46:674-9.
19. Bachorik PS, Albers JJ. Precipitation methods for quantification of lipoproteins. Methods Enzymol 1986;129:78-100.
20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifuge. Clin Chem 1972;18:499-502.
21. Jentzsch AM, Bachmann H, Fürst P, Biesalski HK. Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 1996;20:251-6.
22. Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121-6.
23. McCord JM, Fridovich I. Superoxide dismutase: an enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 1969;244:6049-55.
24. Hansen LG, Warwick WJ. A fluorometric micromethod for serum vitamins A and E. Am J Clin Pathol 1969;51:538-41.
25. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
26. Morris MS, Bostom AG, Jacques PF, Selhub J, Rosenberg IH. Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey. Atherosclerosis 2001;155:195-200.
27. Wiseman SA, Powell JT, Humphries SE, Press M. The magnitude of the hypercholesterolemia of hypothyroidism is associated with variation in the low-density lipoprotein receptor gene. J Clin Endocrinol Metab 1993;77:108-12.
28. Lee WY, Suh JY, Rhee EJ, Park JS, Sung KC, Kim SW. Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lpa levels according to thyroid function status. Arch Med Res 2004;35:540-5.
29. Huesca-Gómez C, Franco M, Luc G, Montaño LF, Massó F, Posadas-Romero C, et al. Chronic hypothyroidism induces abnormal structure of high-density lipoproteins and impaired kinetics of apolipoprotein A-I in the rat. Metabolism 2002;51:443-50.
30. Mayer O Jr, Simon J, Filipovský J, Plásková M, Pikner R. Hypothyroidism in coronary heart disease and its relation to selected risk factors. Vasc Health Risk Manag 2006;4:499-506.
31. Nanda N, Bobby Z, Hamide A. Oxidative stress and protein glycation in primary hypothyroidism: male/female difference. Clin Exp Med 2008;8:101-8.
32. Serdar Z, Aslan K, Dirican M, Sarandöl E, Yeşilbursa D, Serdar A. Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease. Clin Biochem 2006;39:794-803.
33. Erdamar H, Demirci H, Yaman H, Erbil MK, Yakar T, Sancak B, et al. The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status. Clin Chem Lab Med 2008;46:1004-10.
34. Tietz NW. Clinical Guide to Laboratory Tests. 2nd ed. Philadelphia, PA: WB Saunders, 1990:588-9.
35. Csont T, Bereczki E, Bencsik P, Fodor G, Görbe A, Zvara A, et al. Hypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic mice. Cardiovasc Res 2007;76:100-9.
36. Duarte MM, Rocha JB, Moresco RN, Duarte T, Da Cruz IB, Loro VL, et al. Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem 2009;42:666-71.